Literature DB >> 34986291

A New Combination Immunotherapy in Advanced Melanoma.

Adam E Frampton1, Shivan Sivakumar1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34986291     DOI: 10.1056/NEJMe2116892

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry.

Authors:  Beatriz Sánchez-Sendra; Silvia Pérez-Debén; José F González-Muñoz; Amelia Murgui; Carlos Monteagudo
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

Review 2.  Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.

Authors:  Taylor Rager; Adam Eckburg; Meet Patel; Rong Qiu; Shahina Gantiwala; Katrina Dovalovsky; Kelly Fan; Katie Lam; Claire Roesler; Aayush Rastogi; Shruti Gautam; Namrata Dube; Bridget Morgan; S M Nasifuzzaman; Dhruv Ramaswami; Varun Gnanasekar; Jeffrey Smith; Aftab Merchant; Neelu Puri
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.